Update on shortages of prescription medicines in Canada
Daily, millions of Canadians rely on prescription medicines to treat many different diseases and conditions. Drug manufacturers routinely navigate the complex international supply chain to provide safe quality product to Canadian patients. Despite the best efforts of all parties in the pharmaceutical supply chain, shortages of prescription medicines occur in Canada and internationally. Drug shortages have received much attention in the media.
Drug shortages have an impact on patients and health-care providers, who wish to ensure and maintain the best quality of care. Each and every incidence of a prescription drug shortage is of serious concern to Mylan. We take the responsibility of providing continued supply of high-quality, lower-cost generic pharmaceutical products for Canadian patients extremely seriously.
Mylan and members of the Canadian Generic Pharmaceutical Association are working closely with our partners in the prescription drug supply chain, including pharmacies, prescribers, distributors, brand-name pharmaceutical companies and government, to develop solutions to help mitigate the impact of prescription drug shortages on Canadian patients.
As a critical first step Mylan will be participating in a plan which advises and communicates drug shortages to healthcare professionals and patients via two established drug information websites; Vendredi PM and SDIS (University of Saskatchewan Drug Information Service.) These websites, offering information in English and French, will be updated frequently and will meet the needs of the different time zones across the country.
SDIS (University of Saskatchewan Drug Information Service)
Mylan will continue to work with the Health Canada and its partners in the prescription drug supply chain to tackle drug shortages.
If you have any enquiries related to Mylan products, please call Mylan Customer Relations at
1 800 575-1379 or email us at email@example.com